Objectives-To estimate the burden of chronic disease for an elderly Chinese population aged 70 years and over, and to illustrate the use of this information in estimating the economic consequences of disease burden using stroke as an example. Participants-A total of 1902 subjects recruited by random sampling of the old age and disability allowance schemes, which cover over 90% of the Hong Kong elderly population, stratified by sex and five year age groups from age 70 years onwards.
Results-Disease burden figures were highest for arthritis, hypertension, cardiac disease, and peptic ulcer, and were higher in the 70-79 age group than the 80+ age group for some diseases. For stroke, the economic cost based on a population projection for 2001 was estimated to be around HK$1 900 000 000, or US$250 million. Conclusion-Information on the burden of chronic disease is important. It enables the economic consequences to be estimated so that strategies can be developed to prevent diseases with high costs and known effective preventive methods. In any country, the elderly population consumes a large proportion of health care resources. In part, this is a result of the increasing prevalence of chronic diseases with age. Information regarding chronic disease burden in a population is of economic importance since it is needed for estimating resource needs for treating particular diseases, and also for estimating the economic effects of reducing the incidence of certain diseases as a result of population prevention efforts. Information on the occurrence of chronic diseases in the elderly is usually in the form of prevalence or incidence rates from cross sectional and prospective studies. However, from the resource utilisation point of view, it may be more relevant to consider the disease burden, which represents the pool of disease to which there is a constant addition (from development of disease in the previously well population) and elimination (as a result of death of individuals with the disease). Estimation of disease burden would take into account the incidence of the disease over a defined period, the point prevalence at baseline, and death during the same period among those with the disease. In order to provide such an estimate, we used data obtained from a cross sectional and prospective health and social survey of elderly Chinese aged 70 years in Hong Kong to calculate the burden for 10 diseases. The economic consequence is also estimated for one disease (cerebrovascular disease) as an example of the usefulness of such data.
Methods
The survey subjects were recruited by random sampling of the old age and disability allowances schemes, stratified by sex and five year age groups (70-74, 75-79, 80-84, 85-89, 90+).
The old age allowance scheme is a non-means tested scheme; anyone aged 70 years and over and a resident of Hong Kong for five years is eligible to enrol in it. It covers over 90% of the Hong Kong elderly subjects and has been utilised for recruitment of subjects in a previous study on the elderly.' The normal disability and higher disability allowance schemes provide the disabled with further financial assistance. The latter is twice the amount of the former and is meant for the severely disabled who require constant attendance from others in their daily life. Together, all these schemes provide territory-wide coverage of over 90% of the Hong Kong elderly. Those not on the schemes are likely to be the extremely rich.
For the old-old group (aged 80 years and above), 150 subjects were drawn from each of the six strata, male and female by age groups 80-84, 85-89, 90+, so the total old-old sample consisted of 900 subjects. A sample size'of 150 in each of the cells allows the detection of a difference of 15% between the groups with a power of at least 70% and at the 5% level of significance. For the 70-79 years age group, 300 subjects were drawn from each of the four strata-male and female by age groups 70-74 and 75-79. With the assistance of the Social Welfare Department, letters of invitation to participate in the study were sent to the sampled subjects. Letters were sent in batches until the required number in each age group had been obtained. Sixty per cent of the subjects reached gave their consent. The response rate was higher in the 80+ age group compared with the 70-79 age group, suggesting perhaps that the non-responders may have been more fit.
Data collection was done through both personal interview and physical assessment of the respondents. All interviews were conducted at the subjects' place of residence. Personal interview was done using a structured questionnaire. This was based on a number of developed and validated instruments from overseas, but these have been tested and validated in the local setting. The instruments included functional assessment using the Barthel index,2 psychological assessment using the geriatric depression scale3 4 and the information/orientation section of the Clifton assessment procedure for the elderly,5 and symptom assessment (chest pain, dyspnoea, cough) using the WHO angina and dyspnoea questionnaires.' Not all the information collected was used for this report. The questionnaire was translated into spoken Cantonese to minimise variations between interviewers. An instruction manual was designed to accompany the interview schedule.
A pilot study was done during February to March 1991. Fifty subjects from both the community and institutions were included in the pilot study. Modifications of the questions and assessment were done as a result of the pilot study. The survey proper was carried out during the period of July 1991-July 1992. Data collection was done by 31 registered nurses and interviewers with a medical background (medical graduates from Mainland China and medical students). For subjects from whom information could not be directly obtained because of poor cognitive function or illness, the proxy was interviewed instead. For respondents living in the community, the household member responsible for their care was interviewed. For subjects living in institutions, a staff member was used as a proxy. If one assumes that the incidence rate for these diseases and the mortality for the population in this age group with these diseases remain constant, then the actual period of follow up would not affect the calculation of disease burden. In estimating the economic consequence of a particular disease, stroke was used as an example as the epidemiology of the disease from onset to a 20 month period post ictus had been studied in detail for this In large population surveys where information regarding the existence of many different medical conditions is required, it is seldom possible to carry out physical examination and investigations for all subjects. The prevalence of diseases could be underestimated, since many diseases in the elderly may remain asymptomatic. 4 The extent of underestimation is likely to vary between different diseases. Thus, the determination of stroke prevalence by history alone has been shown to have a high sensitivity and specificity,'5 while for diabetes mellitus, up to half of the patients with the disease may remain undiagnosed. '6 For some diseases (cardiac and chronic obstructive airways disease, hypertension, dia-betes, arthritis, and peptic ulcer), the burden is higher for the 70-79 age group, possibly reflecting the reduced life expectancy of subjects with these diseases. However, the greater extent of underdiagnosis in the 80+ age group cannot be excluded, since diagnosis through evidence of contact with the health services will underestimate the true prevalence. From an economic view point, it could be argued that underdiagnosis will not affect cost estimations, since no expenditure will be incurred for undiagnosed diseases. For some diseases, the prevalence figures are similar to those for disease burden figures (arthritis, malignancy), while for most of the other diseases, the disease burden figures are lower. This is particularly so for chronic obstructive airways disease. However, for dementia, the disease burden figure is higher than the prevalence figure. These observations probably reflect differences in life expectancies for subjects with different diseases, and illustrate that the use of disease burden estimation would give more accurate estimations of economic consequences. 
